Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 88.48%8.03M | 138.92%4.26M | -13.00%1.78M | 76.76%2.05M | 54.38%1.16M | 335.62%751.49K | 172.51K |
| Operating revenue | 88.48%8.03M | 138.92%4.26M | -13.00%1.78M | 76.76%2.05M | 54.38%1.16M | 335.62%751.49K | --172.51K |
| Cost of revenue | 115.18%4.62M | 75.16%2.15M | -14.10%1.23M | 88.86%1.43M | 34.21%755.73K | 396.41%563.08K | 113.43K |
| Gross profit | 61.38%3.41M | 278.94%2.12M | -10.46%558.24K | 54.16%623.48K | 114.66%404.43K | 218.90%188.41K | 59.08K |
| Operating expense | 27.97%7.24M | 12.35%5.66M | -22.05%5.04M | 64.34%6.46M | -1.24%3.93M | 120.15%3.98M | 1.81M |
| Selling and administrative expenses | 51.26%5.12M | 19.32%3.39M | -31.91%2.84M | 102.47%4.17M | -11.02%2.06M | 160.55%2.31M | --888.16K |
| -Selling and marketing expense | 107.34%2.53M | 40.70%1.22M | -57.78%867.56K | 163.69%2.05M | 4.50%779.31K | 239.18%745.72K | --219.86K |
| -General and administrative expense | 19.66%2.59M | 9.92%2.17M | -6.76%1.97M | 65.19%2.11M | -18.39%1.28M | 134.69%1.57M | --668.3K |
| Research and development costs | 55.62%16K | 463.76%10.28K | -95.88%1.82K | -67.87%44.29K | 36.37%137.85K | 822.69%101.09K | --10.96K |
| Depreciation amortization depletion | 65.33%333K | -12.97%201.42K | 57.37%231.44K | -6.31%147.07K | -5.20%156.98K | 261.00%165.58K | --45.87K |
| -Depreciation and amortization | 65.33%333K | -12.97%201.42K | 57.37%231.44K | -6.31%147.07K | -5.20%156.98K | 261.00%165.58K | --45.87K |
| Provision for doubtful accounts | ---- | -47.32%13.81K | --26.2K | ---- | ---- | --11.38K | ---- |
| Other operating expenses | -13.58%1.77M | 5.53%2.04M | -7.72%1.94M | 33.14%2.1M | 13.62%1.58M | 60.82%1.39M | --862.69K |
| Operating profit | -8.02%-3.83M | 20.89%-3.54M | 23.29%-4.48M | -65.51%-5.84M | 7.00%-3.53M | -116.81%-3.79M | -1.75M |
| Net non-operating interest income (expenses) | -44.63%-244.97K | 36.96%-169.38K | -619.62%-268.68K | 58.32%-37.34K | -566.27%-89.57K | -207.20%-13.44K | 12.54K |
| Non-operating interest income | ---- | 287.70%3.97K | 1,025.27%1.02K | --91 | ---- | 60.54%42.39K | --26.4K |
| Non-operating interest expense | 41.31%244.97K | -35.73%173.35K | 620.60%269.7K | -58.22%37.43K | 60.44%89.57K | 302.76%55.83K | --13.86K |
| Other net income (expenses) | 591.63%77.99K | 96.80%-15.86K | -2,376.55%-496.4K | -108.91%-20.04K | 802.29%224.99K | 100.82%24.94K | -3.03M |
| Special income (charges) | 202.79%67.52K | 88.47%-65.68K | ---569.56K | ---- | 70.95%-14.54K | ---50.07K | ---- |
| -Less:Impairment of capital assets | -202.79%-67.52K | -88.47%65.68K | --569.56K | ---- | -70.95%14.54K | --50.07K | ---- |
| Other non-operating income (expenses) | -78.98%10.47K | -31.91%49.82K | 465.01%73.16K | -108.37%-20.04K | 219.35%239.53K | 102.48%75.01K | ---3.03M |
| Income before tax | -7.13%-3.99M | 28.91%-3.73M | 4.01%-5.24M | -61.28%-5.46M | 11.17%-3.39M | 18.41%-3.81M | -4.67M |
| Income tax | 0 | 0 | 0 | 0 | 4.4K | 0 | -5.87K |
| Earnings from equity interest net of tax | |||||||
| Net income | -7.13%-3.99M | 28.91%-3.73M | 4.01%-5.24M | -61.07%-5.46M | 11.05%-3.39M | 18.31%-3.81M | -4.67M |
| Net income continuous operations | -7.13%-3.99M | 28.91%-3.73M | 4.01%-5.24M | -61.07%-5.46M | 11.05%-3.39M | 18.31%-3.81M | ---4.67M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | -7.13%-3.99M | 28.91%-3.73M | 4.01%-5.24M | -61.07%-5.46M | 11.05%-3.39M | 18.31%-3.81M | -4.67M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | |||||||
| Net income attributable to common stockholders | -7.13%-3.99M | 28.91%-3.73M | 4.01%-5.24M | -61.07%-5.46M | 11.05%-3.39M | 18.31%-3.81M | -4.67M |
| Diluted earnings per share | |||||||
| Basic earnings per share | |||||||
| Dividend per share | |||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |